Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei.
about
Melioidosis: epidemiology, pathophysiology, and management.Species versus biotype statusDevelopment of Burkholderia mallei and pseudomallei vaccinesStrategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.Protection against Experimental Melioidosis with a Synthetic manno-Heptopyranose Hexasaccharide GlycoconjugateRecombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant.A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate.Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei.An avirulent Burkholderia pseudomallei ∆purM strain with atypical type B LPS: expansion of the toolkit for biosafe studies of melioidosis.Present and future therapeutic strategies for melioidosis and glanders.The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b depositionIntegrative genomic, transcriptional, and proteomic diversity in natural isolates of the human pathogen Burkholderia pseudomalleiProduction of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery.Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates.Characterization of a murine model of melioidosis: comparison of different strains of mice.Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosisThe genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide.A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis.Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.Immunogenic Consensus Sequence T helper Epitopes for a Pan-Burkholderia Biodefense Vaccine.Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor speciesBurkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides.Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in miceDevelopment of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis.Identification of circulating bacterial antigens by in vivo microbial antigen discovery.Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugatesSpecificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies.Characterization of the capsular polysaccharide of Burkholderia (Pseudomonas) pseudomallei 304b.Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species.Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes.Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glandersIn vivo Distribution and Clearance of Purified Capsular Polysaccharide from Burkholderia pseudomallei in a Murine Model.Comparison of O-polysaccharide and hemolysin co-regulated protein as target antigens for serodiagnosis of melioidosisStructural diversity of Burkholderia pseudomallei lipopolysaccharides affects innate immune signaling.Detailed structural analysis of the O-polysaccharide expressed by Burkholderia thailandensis E264.Development of novel O-polysaccharide based glycoconjugates for immunization against glandersDevelopment of Rapid Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Burkholderia pseudomallei.
P2860
Q24522461-465C1BE2-152E-4BF5-AA31-5518EFF719BAQ24554199-2C9EE0FD-CF53-4AB2-A0FC-257E16EB4BE3Q26861271-EF49160C-CA95-4119-BFBA-4B181E68C98EQ28299584-3BBE575D-5B36-4BE7-A7EA-4FCF485BFEAFQ28829950-14DC4A8E-A54B-46F0-AA6A-C95624BB8D3FQ30279061-F3388A5D-9132-4CFB-B6DA-46D18F4C26F9Q30635403-966544BE-F9C1-46BF-A745-34DD58A7A24BQ33601907-3E90507F-12B4-430F-A519-BF304FC69222Q33661479-4B713AD8-2528-4305-AA9D-4CE879AE2592Q33752432-E1E3FFD9-F6D6-458D-A1C8-26DCB3DD0389Q33771536-D20E9027-9F7B-4F3F-BB93-AAEB2D46108AQ33797791-FC51C1C7-D35D-474B-84A6-A535C297CD4CQ33798900-C75B6453-9F6A-4906-93BA-736A4C9B2F2BQ33855630-9C03853A-FE40-475C-81C9-196AD1308DBDQ33965527-F7110AD5-A8C5-4244-BC6D-5D52490BF680Q33991815-6AE16725-76FD-48EE-9FAC-C427C034FEB1Q34001112-D529DF4F-8798-41C8-B5CC-93A24C7D6FE0Q34058969-EA67563B-1CB0-41B8-A576-2E83C08EB999Q34123963-59808B9E-BBD5-4D45-A439-4CEC303CB391Q34130336-48DC86DB-5738-4B6C-851C-657D57E8515EQ34243707-D83A3A33-3B40-462B-815B-F0967028D2EAQ34388865-E46539F8-F900-49D3-9AD0-1A112FA204EDQ34466630-2A27F15A-25F1-416A-A42B-B977DA94296EQ34529504-23042533-79B4-4598-8FE2-6D2BE4B52AC6Q35009671-310250DB-0260-492D-AE05-ECC51675434EQ35126504-224AB7AB-5099-4825-A4CF-A7474B48AA8EQ35187007-BF31B057-D573-4D3D-BF23-44F1E702DC61Q35507434-9A922062-B54F-4228-A209-1C427E739359Q35554658-A15DAF80-A170-4831-B79F-31F3405E7817Q35630032-726CEA1A-D1B2-4CBA-966A-A1FB94E3AEBDQ35799842-7C31A4CA-B916-4116-836D-DDBF4A610F9EQ35805361-1EB64D61-7B12-4AFD-BF54-55874311615FQ35987326-558F4A84-180D-486E-BDC0-CA39BF4AB6D8Q36164961-3D9E0EBF-4CA4-4EFC-AE67-181867DFC2E6Q36219974-2299A30F-6951-499F-B849-7308DDC50C81Q36328111-97E222BD-9E23-4302-A21D-EA5A03989166Q36357954-7D405343-622E-48FF-BEE2-CD025306CF0DQ36392951-3F4A5F35-93F8-4EE7-9546-D4A46ADFE723Q36424795-10201D76-1FAA-4A10-8CFA-6D76404DF9C2Q36834805-84B9B7E2-CA73-469C-B0BA-9AFBB4E3F8DB
P2860
Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei.
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Structural characterization of ...... of Burkholderia pseudomallei.
@ast
Structural characterization of ...... of Burkholderia pseudomallei.
@en
type
label
Structural characterization of ...... of Burkholderia pseudomallei.
@ast
Structural characterization of ...... of Burkholderia pseudomallei.
@en
prefLabel
Structural characterization of ...... of Burkholderia pseudomallei.
@ast
Structural characterization of ...... of Burkholderia pseudomallei.
@en
P2093
P2860
P1476
Structural characterization of ...... s of Burkholderia pseudomallei
@en
P2093
P2860
P304
P407
P577
1995-09-01T00:00:00Z